Clovis Oncology Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (37)

Latest Posts

About This Stock More About This Stock
Tesaro Jumps After Report Of Sale Exploration, Peer Clovis Follows
Article By: The Fly
Friday, November 16, 2018 7:40 PM EDT
Shares of Tesaro (TSRO) jumped in late day trading after Bloomberg said the company is working with advisers to explore a possible sale after receiving takeover interest.
In this article: CLVS, TSRO
Read
Clovis Jumps As Analysts Get More Bullish Following EU Advisory News
Article By: The Fly
Thursday, February 22, 2018 11:47 AM EDT
Shares of Clovis are on the rise after Evercore ISI analyst Steven Breazzano upgraded the stock to Outperform.
In this article: CLVS Also: TSRO
Read
Clovis Oncology Submits Supplemental New Drug Application For Rucaparib
Article By: Business Wire
Monday, October 9, 2017 9:14 PM EDT
CLVS announced today that the company has submitted a supplemental New Drug Application (sNDA) to the FDA for rucaparib as maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer .
In this article: CLVS
Read
XBI Breaks Through On A Strong Week For Biotech
Article By: Rod Raynovich
Friday, September 29, 2017 7:25 PM EDT
The XBI is up 3.17% this week, 46% YTD, compared to only 1.1% WTD for the IBB. The breakthrough gains for the XBI can be attributed to strong performance of top ten holdings that are primarily mid-caps and M&A prospects.
In this article: BMY, ALNY, BMRN, IBB, AMGN, CELG, CLVS, XBI, JUNO, PBYI, SRPT, BLUE, PTCT, ABBV, FMI
Read
Good Day Today: XBI Breaks Through To YTD Highs
Article By: Rod Raynovich
Monday, June 19, 2017 9:31 PM EDT
Tech stocks rebounded today and biotech stocks soared and maintained the market lead in 2017 performance.
In this article: BMY, ALNY, BMRN, INCY, QQQ, AMGN, CLVS, GILD, XBI, XLV, ICPT, BLUE, RDUS, IBB
Read

PARTNER HEADLINES

Latest Tweets for $CLVS

No tweets yet!